Clinical Trials Logo
  1. Home
  2. Blepharitis
  3. NCT01115192
  4. Details
NCT01115192 Clinical Trial

Blephacura Versus Baby Shampoo to Treat Blepharitis

Blepharitis Clinical Trial

Official title:
Blephacura Versus Baby Shampoo to Treat Blepharitis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01115192
Other study ID # OptimaCologne
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2010
Est. completion date December 31, 2010

Study information
Verified date November 2018
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to compare the effectiveness in treatment of chronic blepharitis either with a phospholipid liposome suspension compared to a conventional therapy recommendation using diluted baby shampoo.

Recruitment information / eligibility
Status Completed
Enrollment 144
Est. completion date December 31, 2010
Est. primary completion date December 31, 2010
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- patients with blepharitis

- 100 eyes of 100 patients (50 patients treated with Blephacura, 50 patients treated with diluted baby shampoo) The ratio of female / male is not involved.

Exclusion Criteria:

- all patients that are not included in the group of inclusion criteria

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Group A
Blephacura is a solution with liposomes and used for cleaning of the eye lid to treat blepharitis
• Group B
Diluted Baby Shampoo is used for cleaning of the eye lid to treat blepharitis

Locations
Country Name City State
Germany University Eye Hospital, University of Cologne Cologne NRW

Sponsors (2)
Lead Sponsor Collaborator
University of Cologne Optima Pharmazeutische GmbH

Country where clinical trial is conducted

Germany, 

See also
  Status Clinical Trial Phase
Completed NCT04475432 - Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Phase 2/Phase 3
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Active, not recruiting NCT05629390 - Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study Phase 3
Terminated NCT02938078 - Ocular Comfort and Inflammation in Lid Hygiene Therapy N/A
Completed NCT01408082 - Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Phase 3
Completed NCT01028027 - Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Phase 3
Recruiting NCT04858113 - Short-term Effects on Tear Film (Baby Shampoo vs Blephasol) N/A
Completed NCT00560703 - Treatment of Patients With Blepharitis and Facial Rosacea Phase 2
Recruiting NCT02455895 - Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora N/A
Completed NCT00894530 - The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Phase 2
Completed NCT02386774 - Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa N/A
Completed NCT01808560 - Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery N/A
Completed NCT01089608 - Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Phase 2
Completed NCT00629941 - Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Phase 4
Completed NCT00629590 - Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Phase 4
Completed NCT03926026 - Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis Phase 2
Recruiting NCT04603222 - Evaluation of SUMMIT BRUSH in Treatment of Blepharitis N/A
Completed NCT02218489 - Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Phase 2
Completed NCT00796926 - Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Phase 3
Completed NCT00803452 - Lipids of the Human Tear Film and Their Effect on Tear Stability Phase 4